Wegovy HD goes nationwide

Novo Nordisk has made a higher‑dose Wegovy HD formulation available across the U.S. for adults with obesity. (finance.yahoo.com) The company is also partnering with providers in markets such as Malaysia and testing oral semaglutide in an Alzheimer’s trial, signalling broader clinical and commercial expansion beyond weight loss. (klsescreener.com) (simplywall.st)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.